HEADER TRANSPORT PROTEIN 31-JAN-23 8G0M TITLE STRUCTURE OF COMPLEX BETWEEN TV6.6 AND CD98HC ECD COMPND MOL_ID: 1; COMPND 2 MOLECULE: 4F2 CELL-SURFACE ANTIGEN HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CD98 HEAVY CHAIN, CD98HC, 4F2HC,4F2 HEAVY CHAIN ANTIGEN, COMPND 5 LYMPHOCYTE ACTIVATION ANTIGEN 4F2 LARGE SUBUNIT,SOLUTE CARRIER FAMILY COMPND 6 3 MEMBER 2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: TV 6.6 FC FRAGMENT; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC3A2, MDU1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630; SOURCE 11 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS TRANSPORT VEHICLE, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.S.KARIOLIS,K.LEXA,N.P.D.LIAU,D.SRIVASTAVA,H.TRAN,R.C.WELLS REVDAT 2 06-NOV-24 8G0M 1 REMARK REVDAT 1 18-OCT-23 8G0M 0 JRNL AUTH K.S.CHEW,R.C.WELLS,A.MOSHKFOROUSH,D.CHAN,K.J.LECHTENBERG, JRNL AUTH 2 H.L.TRAN,J.CHOW,D.J.KIM,Y.ROBLES-COLMENARES,D.B.SRIVASTAVA, JRNL AUTH 3 R.K.TONG,M.TONG,K.XA,A.YANG,Y.ZHOU,P.AKKAPEDDI,L.ANNAMALAI, JRNL AUTH 4 K.BAJC,M.BLANCHETTE,G.M.CHERF,T.K.EARR,A.GILL,D.HUYNH,D.JOY, JRNL AUTH 5 K.N.KNIGHT,D.LAC,A.W.LEUNG,K.W.LEXA,N.P.D.LIAU,I.BECERRA, JRNL AUTH 6 M.MALFAVON,J.MCINNES,H.N.NGUYEN,E.I.LOZANO,M.E.PIZZO, JRNL AUTH 7 E.ROCHE,P.SACAYON,M.E.K.CALVERT,R.DANEMAN,M.S.DENNIS, JRNL AUTH 8 J.DUQUE,K.GADKAR,J.W.LEWCOCK,C.S.MAHON,R.MEISNER,H.SOLANOY, JRNL AUTH 9 R.G.THORNE,R.J.WATTS,Y.J.Y.ZUCHERO,M.S.KARIOLIS JRNL TITL CD98HC IS A TARGET FOR BRAIN DELIVERY OF BIOTHERAPEUTICS. JRNL REF NAT COMMUN V. 14 5053 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37598178 JRNL DOI 10.1038/S41467-023-40681-4 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.S.CHEW,R.C.WELLS,A.MOSHKFOROUSH,D.CHAN,K.J.LECHTENBERG, REMARK 1 AUTH 2 H.L.TRAN,J.CHOW,D.J.KIM,Y.ROBLES-COLMENARES,D.B.SRIVASTAVA, REMARK 1 AUTH 3 R.K.TONG,M.TONG,K.XA,A.YANG,Y.ZHOU,P.AKKAPEDDI,L.ANNAMALAI, REMARK 1 AUTH 4 K.BAJC,M.BLANCHETTE,G.M.CHERF,T.K.EARR,A.GILL,D.HUYNH,D.JOY, REMARK 1 AUTH 5 K.N.KNIGHT,D.LAC,A.W.LEUNG,K.W.LEXA,N.P.D.LIAU,I.BECERRA, REMARK 1 AUTH 6 M.MALFAVON,J.MCINNES,H.N.NGUYEN,E.I.LOZANO,M.E.PIZZO, REMARK 1 AUTH 7 E.ROCHE,P.SACAYON,M.E.K.CALVERT,R.DANEMAN,M.S.DENNIS, REMARK 1 AUTH 8 J.DUQUE,K.GADKAR,J.W.LEWCOCK,C.S.MAHON,R.MEISNER,H.SOLANOY, REMARK 1 AUTH 9 R.G.THORNE,R.J.WATTS,Y.J.Y.ZUCHERO,M.S.KARIOLIS REMARK 1 TITL CD98HC IS A TARGET FOR BRAIN DELIVERY OF BIOTHERAPEUTICS. REMARK 1 REF NAT COMMUN V. 14 5053 2023 REMARK 1 REFN ESSN 2041-1723 REMARK 1 PMID 37598178 REMARK 1 DOI 10.1038/S41596-019-0206-Y REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0403 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 45610 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.119 REMARK 3 FREE R VALUE TEST SET COUNT : 2335 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3164 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3340 REMARK 3 BIN FREE R VALUE SET COUNT : 162 REMARK 3 BIN FREE R VALUE : 0.3640 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4894 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 129 REMARK 3 SOLVENT ATOMS : 157 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12800 REMARK 3 B22 (A**2) : 0.03200 REMARK 3 B33 (A**2) : -0.16100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.224 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.194 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.165 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.950 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5146 ; 0.006 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 4833 ; 0.001 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6988 ; 1.219 ; 1.653 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11184 ; 0.420 ; 1.571 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 617 ; 6.851 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 25 ; 6.418 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 844 ;14.795 ;10.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 794 ; 0.054 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5833 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1147 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 906 ; 0.214 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 65 ; 0.157 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2455 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 220 ; 0.161 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2477 ; 5.675 ; 6.349 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2477 ; 5.675 ; 6.349 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3091 ; 8.181 ;11.409 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3092 ; 8.179 ;11.409 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2669 ; 5.801 ; 6.773 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2670 ; 5.801 ; 6.773 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3897 ; 8.508 ;12.199 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3898 ; 8.507 ;12.199 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 8G0M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1000271278. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-21 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.18071 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45610 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 44.681 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.99400 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6IRS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% GLYCEROL, 0.1 M HEPES PH 7.5, 5% REMARK 280 PEG 3000, 30% PEG 40, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.83850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.83850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 68.07600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 83.56300 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 68.07600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 83.56300 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 41.83850 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 68.07600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 83.56300 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 41.83850 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 68.07600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 83.56300 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 607 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 707 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 212 REMARK 465 LEU A 213 REMARK 465 ASP A 407 REMARK 465 SER A 408 REMARK 465 GLY A 409 REMARK 465 ALA A 630 REMARK 465 GLU A 631 REMARK 465 ASN A 632 REMARK 465 LEU A 633 REMARK 465 TYR A 634 REMARK 465 PHE A 635 REMARK 465 GLN A 636 REMARK 465 ASP B 221 REMARK 465 LYS B 222 REMARK 465 THR B 223 REMARK 465 HIS B 224 REMARK 465 THR B 225 REMARK 465 CYS B 226 REMARK 465 PRO B 227 REMARK 465 PRO B 228 REMARK 465 CYS B 229 REMARK 465 PRO B 230 REMARK 465 ALA B 231 REMARK 465 PRO B 232 REMARK 465 GLU B 233 REMARK 465 LEU B 234 REMARK 465 LEU B 235 REMARK 465 GLY B 236 REMARK 465 GLY B 237 REMARK 465 PRO B 445 REMARK 465 GLY B 446 REMARK 465 LYS B 447 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ2 LYS B 246 HO4 GAL C 6 1.15 REMARK 500 HG1 THR A 380 H SER A 382 1.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 274 34.14 -94.70 REMARK 500 PHE A 319 -153.55 57.29 REMARK 500 GLN A 322 40.37 -144.07 REMARK 500 SER A 371 142.76 -173.55 REMARK 500 ASP A 373 33.51 -95.13 REMARK 500 ALA A 438 -38.07 -146.78 REMARK 500 ALA A 486 57.60 -159.67 REMARK 500 HIS A 538 37.21 -155.77 REMARK 500 ASP A 558 -116.68 48.94 REMARK 500 SER B 383 -166.55 -111.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 706 DISTANCE = 6.61 ANGSTROMS DBREF 8G0M A 212 630 UNP P08195 4F2_HUMAN 212 630 DBREF 8G0M B 221 447 PDB 8G0M 8G0M 221 447 SEQADV 8G0M GLU A 631 UNP P08195 EXPRESSION TAG SEQADV 8G0M ASN A 632 UNP P08195 EXPRESSION TAG SEQADV 8G0M LEU A 633 UNP P08195 EXPRESSION TAG SEQADV 8G0M TYR A 634 UNP P08195 EXPRESSION TAG SEQADV 8G0M PHE A 635 UNP P08195 EXPRESSION TAG SEQADV 8G0M GLN A 636 UNP P08195 EXPRESSION TAG SEQRES 1 A 425 GLU LEU PRO ALA GLN LYS TRP TRP HIS THR GLY ALA LEU SEQRES 2 A 425 TYR ARG ILE GLY ASP LEU GLN ALA PHE GLN GLY HIS GLY SEQRES 3 A 425 ALA GLY ASN LEU ALA GLY LEU LYS GLY ARG LEU ASP TYR SEQRES 4 A 425 LEU SER SER LEU LYS VAL LYS GLY LEU VAL LEU GLY PRO SEQRES 5 A 425 ILE HIS LYS ASN GLN LYS ASP ASP VAL ALA GLN THR ASP SEQRES 6 A 425 LEU LEU GLN ILE ASP PRO ASN PHE GLY SER LYS GLU ASP SEQRES 7 A 425 PHE ASP SER LEU LEU GLN SER ALA LYS LYS LYS SER ILE SEQRES 8 A 425 ARG VAL ILE LEU ASP LEU THR PRO ASN TYR ARG GLY GLU SEQRES 9 A 425 ASN SER TRP PHE SER THR GLN VAL ASP THR VAL ALA THR SEQRES 10 A 425 LYS VAL LYS ASP ALA LEU GLU PHE TRP LEU GLN ALA GLY SEQRES 11 A 425 VAL ASP GLY PHE GLN VAL ARG ASP ILE GLU ASN LEU LYS SEQRES 12 A 425 ASP ALA SER SER PHE LEU ALA GLU TRP GLN ASN ILE THR SEQRES 13 A 425 LYS GLY PHE SER GLU ASP ARG LEU LEU ILE ALA GLY THR SEQRES 14 A 425 ASN SER SER ASP LEU GLN GLN ILE LEU SER LEU LEU GLU SEQRES 15 A 425 SER ASN LYS ASP LEU LEU LEU THR SER SER TYR LEU SER SEQRES 16 A 425 ASP SER GLY SER THR GLY GLU HIS THR LYS SER LEU VAL SEQRES 17 A 425 THR GLN TYR LEU ASN ALA THR GLY ASN ARG TRP CYS SER SEQRES 18 A 425 TRP SER LEU SER GLN ALA ARG LEU LEU THR SER PHE LEU SEQRES 19 A 425 PRO ALA GLN LEU LEU ARG LEU TYR GLN LEU MET LEU PHE SEQRES 20 A 425 THR LEU PRO GLY THR PRO VAL PHE SER TYR GLY ASP GLU SEQRES 21 A 425 ILE GLY LEU ASP ALA ALA ALA LEU PRO GLY GLN PRO MET SEQRES 22 A 425 GLU ALA PRO VAL MET LEU TRP ASP GLU SER SER PHE PRO SEQRES 23 A 425 ASP ILE PRO GLY ALA VAL SER ALA ASN MET THR VAL LYS SEQRES 24 A 425 GLY GLN SER GLU ASP PRO GLY SER LEU LEU SER LEU PHE SEQRES 25 A 425 ARG ARG LEU SER ASP GLN ARG SER LYS GLU ARG SER LEU SEQRES 26 A 425 LEU HIS GLY ASP PHE HIS ALA PHE SER ALA GLY PRO GLY SEQRES 27 A 425 LEU PHE SER TYR ILE ARG HIS TRP ASP GLN ASN GLU ARG SEQRES 28 A 425 PHE LEU VAL VAL LEU ASN PHE GLY ASP VAL GLY LEU SER SEQRES 29 A 425 ALA GLY LEU GLN ALA SER ASP LEU PRO ALA SER ALA SER SEQRES 30 A 425 LEU PRO ALA LYS ALA ASP LEU LEU LEU SER THR GLN PRO SEQRES 31 A 425 GLY ARG GLU GLU GLY SER PRO LEU GLU LEU GLU ARG LEU SEQRES 32 A 425 LYS LEU GLU PRO HIS GLU GLY LEU LEU LEU ARG PHE PRO SEQRES 33 A 425 TYR ALA ALA GLU ASN LEU TYR PHE GLN SEQRES 1 B 227 ASP LYS THR HIS THR CYS PRO PRO CYS PRO ALA PRO GLU SEQRES 2 B 227 LEU LEU GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS SEQRES 3 B 227 PRO LYS ASP THR LEU MET ILE SER ARG THR PRO GLU VAL SEQRES 4 B 227 THR CYS VAL VAL VAL ASP VAL SER HIS GLU ASP PRO GLU SEQRES 5 B 227 VAL LYS PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS SEQRES 6 B 227 ASN ALA LYS THR LYS PRO ARG GLU GLU GLN TYR ASN SER SEQRES 7 B 227 THR TYR ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN SEQRES 8 B 227 ASP TRP LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER SEQRES 9 B 227 ASN LYS ALA LEU PRO ALA PRO ILE GLU LYS THR ILE SER SEQRES 10 B 227 LYS ALA LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR THR SEQRES 11 B 227 LEU PRO PRO SER ARG ASP GLU LEU THR LYS ASN GLN VAL SEQRES 12 B 227 SER LEU THR CYS LEU VAL LYS GLY PHE TYR PRO SER ASP SEQRES 13 B 227 ILE ALA VAL LEU TRP ASN SER ARG PHE VAL LEU GLU ASN SEQRES 14 B 227 ASN TYR LYS THR THR PRO PRO VAL LEU ASP SER ASP GLY SEQRES 15 B 227 SER PHE PHE LEU TYR SER LYS LEU THR VAL ASP LYS SER SEQRES 16 B 227 ARG TRP GLN GLN GLY ASN ILE PHE ALA CYS ASN VAL TYR SEQRES 17 B 227 HIS GLU ALA LEU HIS ASN HIS TYR THR PHE LYS ASN LEU SEQRES 18 B 227 ALA LEU SER PRO GLY LYS HET NAG C 1 26 HET NAG C 2 27 HET BMA C 3 20 HET MAN C 4 21 HET NAG C 5 27 HET GAL C 6 22 HET MAN C 7 22 HET FUC C 8 21 HET EDO A 701 10 HET PG4 A 702 31 HET EDO A 703 10 HET EDO B 501 10 HET EDO B 502 10 HET EDO B 503 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM EDO 1,2-ETHANEDIOL HETNAM PG4 TETRAETHYLENE GLYCOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 3 MAN 2(C6 H12 O6) FORMUL 3 GAL C6 H12 O6 FORMUL 3 FUC C6 H12 O5 FORMUL 4 EDO 5(C2 H6 O2) FORMUL 5 PG4 C8 H18 O5 FORMUL 10 HOH *157(H2 O) HELIX 1 AA1 LYS A 217 THR A 221 5 5 HELIX 2 AA2 ASP A 229 GLY A 235 1 7 HELIX 3 AA3 ASN A 240 GLY A 246 1 7 HELIX 4 AA4 ARG A 247 LEU A 254 1 8 HELIX 5 AA5 SER A 286 LYS A 300 1 15 HELIX 6 AA6 GLN A 322 GLY A 341 1 20 HELIX 7 AA7 ASP A 349 LEU A 353 5 5 HELIX 8 AA8 ASP A 355 SER A 371 1 17 HELIX 9 AA9 ASP A 384 GLU A 393 1 10 HELIX 10 AB1 THR A 411 THR A 426 1 16 HELIX 11 AB2 LEU A 440 PHE A 444 5 5 HELIX 12 AB3 PRO A 446 GLN A 448 5 3 HELIX 13 AB4 LEU A 449 PHE A 458 1 10 HELIX 14 AB5 GLY A 469 GLY A 473 5 5 HELIX 15 AB6 ASP A 475 LEU A 479 5 5 HELIX 16 AB7 SER A 504 MET A 507 5 4 HELIX 17 AB8 THR A 508 GLU A 514 1 7 HELIX 18 AB9 SER A 518 GLU A 533 1 16 HELIX 19 AC1 GLU A 533 GLY A 539 1 7 HELIX 20 AC2 PRO A 584 SER A 588 5 5 HELIX 21 AC3 LYS B 246 MET B 252 1 7 HELIX 22 AC4 LEU B 309 ASN B 315 1 7 HELIX 23 AC5 SER B 354 LYS B 360 5 7 HELIX 24 AC6 LYS B 414 GLN B 419 1 6 HELIX 25 AC7 LEU B 432 ASN B 434 5 3 SHEET 1 AA1 8 LEU A 399 THR A 401 0 SHEET 2 AA1 8 LEU A 375 GLY A 379 1 N ALA A 378 O LEU A 399 SHEET 3 AA1 8 GLY A 344 VAL A 347 1 N PHE A 345 O ILE A 377 SHEET 4 AA1 8 ARG A 303 ASP A 307 1 N LEU A 306 O GLY A 344 SHEET 5 AA1 8 GLY A 258 LEU A 261 1 N LEU A 259 O ILE A 305 SHEET 6 AA1 8 LEU A 224 ILE A 227 1 N ILE A 227 O VAL A 260 SHEET 7 AA1 8 THR A 463 SER A 467 1 O PHE A 466 N ARG A 226 SHEET 8 AA1 8 SER A 432 TRP A 433 1 N TRP A 433 O THR A 463 SHEET 1 AA2 2 HIS A 265 LYS A 266 0 SHEET 2 AA2 2 ASP A 276 ILE A 280 -1 O GLN A 279 N LYS A 266 SHEET 1 AA3 6 ASP A 540 PHE A 544 0 SHEET 2 AA3 6 LEU A 550 HIS A 556 -1 O HIS A 556 N ASP A 540 SHEET 3 AA3 6 ARG A 562 ASN A 568 -1 O VAL A 565 N TYR A 553 SHEET 4 AA3 6 GLY A 621 PHE A 626 -1 O LEU A 624 N LEU A 564 SHEET 5 AA3 6 LYS A 592 SER A 598 -1 N LEU A 596 O LEU A 623 SHEET 6 AA3 6 PRO A 608 GLU A 610 -1 O LEU A 609 N ALA A 593 SHEET 1 AA4 2 LEU A 574 SER A 575 0 SHEET 2 AA4 2 LYS A 615 LEU A 616 -1 O LEU A 616 N LEU A 574 SHEET 1 AA5 4 SER B 239 PHE B 243 0 SHEET 2 AA5 4 GLU B 258 VAL B 266 -1 O VAL B 262 N PHE B 241 SHEET 3 AA5 4 TYR B 300 THR B 307 -1 O VAL B 302 N VAL B 263 SHEET 4 AA5 4 LYS B 288 THR B 289 -1 N LYS B 288 O VAL B 305 SHEET 1 AA6 4 SER B 239 PHE B 243 0 SHEET 2 AA6 4 GLU B 258 VAL B 266 -1 O VAL B 262 N PHE B 241 SHEET 3 AA6 4 TYR B 300 THR B 307 -1 O VAL B 302 N VAL B 263 SHEET 4 AA6 4 GLU B 293 GLU B 294 -1 N GLU B 293 O ARG B 301 SHEET 1 AA7 4 VAL B 282 VAL B 284 0 SHEET 2 AA7 4 LYS B 274 VAL B 279 -1 N VAL B 279 O VAL B 282 SHEET 3 AA7 4 TYR B 319 SER B 324 -1 O LYS B 322 N ASN B 276 SHEET 4 AA7 4 ILE B 332 ILE B 336 -1 O ILE B 332 N VAL B 323 SHEET 1 AA8 4 GLN B 347 LEU B 351 0 SHEET 2 AA8 4 GLN B 362 PHE B 372 -1 O LEU B 368 N TYR B 349 SHEET 3 AA8 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 AA8 4 TYR B 391 THR B 393 -1 N LYS B 392 O LYS B 409 SHEET 1 AA9 4 GLN B 347 LEU B 351 0 SHEET 2 AA9 4 GLN B 362 PHE B 372 -1 O LEU B 368 N TYR B 349 SHEET 3 AA9 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 AA9 4 VAL B 397 LEU B 398 -1 N VAL B 397 O PHE B 405 SHEET 1 AB1 4 LEU B 387 GLU B 388 0 SHEET 2 AB1 4 ALA B 378 SER B 383 -1 N TRP B 381 O GLU B 388 SHEET 3 AB1 4 PHE B 423 TYR B 428 -1 O ASN B 426 N LEU B 380 SHEET 4 AB1 4 TYR B 436 LEU B 441 -1 O LYS B 439 N CYS B 425 SSBOND 1 CYS B 261 CYS B 321 1555 1555 2.04 SSBOND 2 CYS B 367 CYS B 425 1555 1555 2.06 LINK ND2 ASN B 297 C1 NAG C 1 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O6 NAG C 1 C1 FUC C 8 1555 1555 1.40 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.39 LINK O6 BMA C 3 C1 MAN C 4 1555 1555 1.40 LINK O3 BMA C 3 C1 MAN C 7 1555 1555 1.40 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.44 LINK O4 NAG C 5 C1 GAL C 6 1555 1555 1.44 CISPEP 1 GLY A 262 PRO A 263 0 6.49 CISPEP 2 TYR B 373 PRO B 374 0 -6.57 CRYST1 136.152 167.126 83.677 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007345 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005984 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011951 0.00000